Drug initiation and escalation strategies of vasodilator therapies for Raynaud's phenomenon: can we treat to target?

MLA

Hughes, Michael, et al. “Drug Initiation and Escalation Strategies of Vasodilator Therapies for Raynaud’s Phenomenon: Can We Treat to Target?” Rheumatology, vol. 59, no. 3, Mar. 2020, pp. 464–66. EBSCOhost, https://doi.org/10.1093/rheumatology/kez522.

APA

Hughes, M., Khanna, D., & Pauling, J. D. (2020). Drug initiation and escalation strategies of vasodilator therapies for Raynaud’s phenomenon: can we treat to target? Rheumatology, 59(3), 464–466. https://doi.org/10.1093/rheumatology/kez522

Chicago

Hughes, Michael, Dinesh Khanna, and John D Pauling. 2020. “Drug Initiation and Escalation Strategies of Vasodilator Therapies for Raynaud’s Phenomenon: Can We Treat to Target?” Rheumatology 59 (3): 464–66. doi:10.1093/rheumatology/kez522.